91
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

      research-article
      , MD, PhD, , MSc, , PhD, , MPH, , PhD, , MA, , MD, MPH, , MD, MPH, , MD, , PhD, , PhD, , MD, , PhD, , PhD, , MD, MPH, , MD, MSc, , MD, PhD, , MD, , MD, PhD, , ScD, , MD, MSc, , PhD, , MD, PhD, , MD, , MD, , MD, PhD, , PhD, , MD, MS, , MD, MS, MSc, , MB, PhD, , MD, PhD, , MD, PhD, , MD, ScM
      Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
      Blackwell Publishing Ltd
      atrial fibrillation, epidemiology, risk factors

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Tools for the prediction of atrial fibrillation (AF) may identify high‐risk individuals more likely to benefit from preventive interventions and serve as a benchmark to test novel putative risk factors.

          Methods and Results

          Individual‐level data from 3 large cohorts in the United States (Atherosclerosis Risk in Communities [ARIC] study, the Cardiovascular Health Study [CHS], and the Framingham Heart Study [FHS]), including 18 556 men and women aged 46 to 94 years (19% African Americans, 81% whites) were pooled to derive predictive models for AF using clinical variables. Validation of the derived models was performed in 7672 participants from the Age, Gene and Environment—Reykjavik study (AGES) and the Rotterdam Study (RS). The analysis included 1186 incident AF cases in the derivation cohorts and 585 in the validation cohorts. A simple 5‐year predictive model including the variables age, race, height, weight, systolic and diastolic blood pressure, current smoking, use of antihypertensive medication, diabetes, and history of myocardial infarction and heart failure had good discrimination (C‐statistic, 0.765; 95% CI, 0.748 to 0.781). Addition of variables from the electrocardiogram did not improve the overall model discrimination (C‐statistic, 0.767; 95% CI, 0.750 to 0.783; categorical net reclassification improvement, −0.0032; 95% CI, −0.0178 to 0.0113). In the validation cohorts, discrimination was acceptable (AGES C‐statistic, 0.664; 95% CI, 0.632 to 0.697 and RS C‐statistic, 0.705; 95% CI, 0.664 to 0.747) and calibration was adequate.

          Conclusion

          A risk model including variables readily available in primary care settings adequately predicted AF in diverse populations from the United States and Europe.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

          Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents. We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions ("general CVD" algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P<0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non-laboratory-based predictors. A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

            Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050. Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997. Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. A total of 17 974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

              To determine the independent risk factors for atrial fibrillation. Cohort study. The Framingham Heart Study. A total of 2090 men and 2641 women members of the original cohort, free of a history of atrial fibrillation, between the ages of 55 and 94 years. Sex-specific multiple logistic regression models to identify independent risk factors for atrial fibrillation, including age, smoking, diabetes, electrocardiographic left ventricular hypertrophy, hypertension, myocardial infarction, congestive heart failure, and valve disease. During up to 38 years of follow-up, 264 men and 298 women developed atrial fibrillation. After adjusting for age and other risk factors for atrial fibrillation, men had a 1.5 times greater risk of developing atrial fibrillation than women. In the full multivariable model, the odds ratio (OR) of atrial fibrillation for each decade of advancing age was 2.1 for men and 2.2 for women (P < .0001). In addition, after multivariable adjustment, diabetes (OR, 1.4 for men and 1.6 for women), hypertension (OR, 1.5 for men and 1.4 for women), congestive heart failure (OR, 4.5 for men and 5.9 for women), and valve disease (OR, 1.8 for men and 3.4 for women) were significantly associated with risk for atrial fibrillation in both sexes. Myocardial infarction (OR, 1.4) was significantly associated with the development of atrial fibrillation in men. Women were significantly more likely than men to have valvular heart disease as a risk factor for atrial fibrillation. The multivariable models were largely unchanged after eliminating subjects with valvular heart disease. In addition to intrinsic cardiac causes such as valve disease and congestive heart failure, risk factors for cardiovascular disease also predispose to atrial fibrillation. Modification of risk factors for cardiovascular disease may have the added benefit of diminishing the incidence of atrial fibrillation.
                Bookmark

                Author and article information

                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                ahaoa
                jah3
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                Blackwell Publishing Ltd
                2047-9980
                April 2013
                24 April 2013
                : 2
                : 2
                : e000102
                Affiliations
                [1 ]Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN (A.A.)
                [2 ]Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands (B.P.K., C.W.J., J.C.W., A.H., B.C.S.)
                [3 ]Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands (B.C.S.)
                [4 ]Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands (B.C.S.)
                [5 ]Icelandic Heart Association, Research Institute, Kopavogur, Iceland (T.A., V.G.)
                [6 ]The University of Iceland, Reykjavik, Iceland (T.A., V.G.)
                [7 ]Department of Biostatistics, Boston University School of Public Health, Boston, MA (K.A.S., M.J.P., C.B.M.)
                [8 ]Department of Epidemiology , Boston University School of Public Health, Boston, MA (E.J.B.)
                [9 ]Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA (S.A.L., P.T.E.)
                [10 ]Division of Cardiology, Department of Medicine, University of Washington, Seattle (N.S.)
                [11 ]Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle (N.S.)
                [12 ]Department of Biostatistics, University of Washington, Seattle, WA (R.A.K.)
                [13 ]Department of Epidemiology, University of Washington, Seattle, WA (S.R.H.)
                [14 ]National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (M.F.S., J.F., J.W.M., D.D.M.M., M.G.L., D.L., E.J.B.)
                [15 ]Netherlands Consortium for Healthy Aging (NCHA), The Netherlands (C.W.J., J.C.W., A.H., B.C.S.)
                [16 ]Department of Medicine, Boston University School of Medicine, Boston, MA (J.W.M., E.J.B.)
                [17 ]Department of Health Sciences Research, Mayo Clinic, Rochester, MN (A.M.C.)
                [18 ]Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA (M.F.S., S.A.L., P.T.E.)
                [19 ]Department of General and Interventional Cardiology, University Heart Center Hamburg‐Eppendorf, Germany (R.B.S.)
                [20 ]Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC (S.K.A.)
                [21 ]Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC (D.C.)
                [22 ]Division of Public Health Sciences, Wake Forest School of Medicine, Winston‐Salem, NC (G.L.B.)
                [23 ]Laboratory of Epidemiology, Demography, and Biometry, National Institute of Aging, National Institutes of Health, Bethesda, MD (L.J.L., T.B.H.)
                [24 ]Center for Population Studies, NHLBI, Bethesda, MD (D.L.)
                [25 ]Division of Cardiology, University of Maryland Medical Center, Baltimore, MD (J.S.G.)
                [26 ]Department of Medicine I, University Hospital Munich, Campus Grosshadern, Ludwig‐Maximilians University, Munich, Germany (M.F.S., S.)
                [27 ]Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston‐Salem, NC (E.Z.S.)
                [28 ]Inspectorate for Health Care, The Hague, The Netherlands (B.C.S.)
                [29 ]Munich Heart Alliance, Munich, Germany (S.)
                [30 ]Department of Medicine and Quantitative Health Sciences, University of Massachusetts, Worcester, MA (D.D.M.M.)
                [31 ]Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (D.D.M.M.)
                Author notes
                Correspondence to: Alvaro Alonso, MD, PhD, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota 1300 S 2nd St, Suite 300, Minneapolis, MN 55454. E‐mail: alonso@ 123456umn.edu , and Emelia J. Benjamin, MD, ScM, Boston University School of Medicine, Framingham Heart Study, 73 Mt Wayte Ave, Suite 2, Framingham, MA 01702. Email: emelia@ 123456bu.edu .

                This article was handled independently by Peter Wilson, MD, as Guest Editor.

                Drs Alonso, Krijthe, Aspelund, and Stepas contributed equally to the manuscript.

                Accompanying Tables S1 through S4, Figure S1, and the AF risk score calculator are available at http://jaha.ahajournals.org/content/2/2/e000102.full

                Article
                jah3180
                10.1161/JAHA.112.000102
                3647274
                23537808
                ad813574-db59-4487-8ac2-9344fbeed6b1
                © 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley-Blackwell.

                This is an Open Access article under the terms of the Creative Commons Attribution Noncommercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 17 October 2012
                : 29 January 2013
                Categories
                Original Research
                Epidemiology

                Cardiovascular Medicine
                atrial fibrillation,epidemiology,risk factors
                Cardiovascular Medicine
                atrial fibrillation, epidemiology, risk factors

                Comments

                Comment on this article